Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD133 (AC133) expression on AML cells and progenitors.

Cytotherapy - 1 Jan 2001

Vercauteren S M, Sutherland H J

Abstract excerpt

BACKGROUND: AML blasts differ in their functional capability, creating a hierarchy of progenitors. CD133 (AC133) is a newly described transmembrane protein expressed on CD34(+) and CD34(-) normal progenitors. We characterized the prognostic significance of CD133 expression in AML and expression of CD133 on AML progenitors thought to be responsible for maintaining this disease. METHODS: AML cells from 102 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Antigens, CD
Share to Cell Separation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Transplantation

Share to Leukemia, Myeloid

Share to Mice, Inbred NOD

Share to Mice, SCID

Share to Myeloid Progenitor Cells

Source

Identifiers

PMID: 11953029
DOI: 10.1080/146532401317248054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD133 (AC133) expression on AML cells and progenitors.PMID 11953029Read ↗

Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).Semantic proximity Read ↗

CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.Semantic proximity Read ↗

CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cellsSemantic proximity Read ↗

Expression of AC133, a Novel Hematopoietic Precursor Antigen, on Acute Myeloid Leukemia CellsSemantic proximity Read ↗

Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.Semantic proximity Read ↗

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia.Semantic proximity Read ↗

Expression of CD133 on leukemia-initiating cells in childhood ALL.Semantic proximity Read ↗

Global Gene Expression Profile of Human Cord Blood–Derived CD133+ CellsSemantic proximity Read ↗

Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.Semantic proximity Read ↗

The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.Semantic proximity Read ↗

CD133: molecule of the momentSemantic proximity Read ↗

Characterization of a hierarchy in human acute myeloid leukemia progenitor cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.